Considerations for the pre-clinical evaluation of new psychiatric drugs: A case study with phenothiazine-like tranquilizers Samuel Irwin Reviews Pages: 259 - 287
Controlled psychopharmacological research in private psychiatric practice K. RickelsR. B. CattellH. G. Aaronson Original Investigations Pages: 288 - 306
Zur Beeinflussung der Nahrungsaufnahme durch Psychopharmaka Klaus OpitzAyotunde Akinlaja Originalarbeiten Pages: 307 - 319
A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate Albert A. KurlandJulia H. Richardson Clinical Reports Pages: 320 - 327
Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients Thomas E. HanlonCarlos SchoenrichAlbert A. Kurland Clinical Reports Pages: 328 - 339
Clinical prediction of insightful response to a single large dose of LSD Delmer C. EggertCharles Shagass Clinical Reports Pages: 340 - 346
The effects of scopolamine and atropine on the performance of an exercise-avoidance test by dogs J. H. MennearG. K. SamuelJ. K. Kodama Short Communications Pages: 347 - 350
Pharmakologische und klinische Eigenschaften eines neuen Butyrophenon-Derivates (FR 33) R. KuhnM. TaeschlerJ. Schoch Kurze Originalmitteilungen Pages: 351 - 362
